FDA Adverse Event Injury Summary report: N

PROSORBA COLUMN

MDR report key: 81958 · Received April 2, 1997

Report

Report Number
3023288-1997-00002
Event Type
Injury
Date Received
April 2, 1997
Date of Event
March 3, 1997
Report Date
April 1, 1997
Manufacturer
CYPRESS BIOSCIENCE, INC. (FORMERLY IMRE CORP)
Product Code
LQQ
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
TX, US
Reporter Occupation
NURSE

Narratives

Description of Event or Problem · 1

PT WITH A DIAGNOSIS OF HEMOLYIC UREMIC SYNDROME (HUS) WAS TREATED WITH HIS FIRST COLUM TREATMENT ON 3/30/97. APPROX 35 MINS INTO PROCEDURE PT COMPLAINED OF FEELING NAUSEOUS. AT THIS TIME IT WAS NOTED THAT HIS BLOOD PRESSURE WAS 78.47 AND HE WAS VERY PALE. HE VOMITED A LARGE AMOUNT AND THEN LOST CONSCIOUSNESS. PROCEDURE WAS PUT IN A TRENDELENBERG'S POSITION. ACCORDING TO NURSE, PT BECAME RESPONSIVE 2 OR 3 MINUTES LATER. PHYSICIAN WAS CALLED AND HE ORDERED THE PROCEDURE DISCONTINUED AND 500CC HISPAN WAS GIVEN TO PT. PT HAD BEEN PREMEDICATED WITH BENEDRYL AND TYLENOL BEFORE TREATMENT WITH COLUMN. ONE HOUR POST-TREATMENT DISCONTINUATION. PT'S VITAL SIGNS WERE NORMAL. PT WAS KEPT IN HOSP OVERNIGHT AND DISCHARGED NEXT DAY. PT HAS BEEN ON AN ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITOR MEDICATION LOTENSION, WHICH HAD BEEN DISCONTINUED ON 2/27/97. USE OF COLUMN IS CONTRADICTED IN PTS RECEIVING ACE INHIBITOR MEDICATIONS. PT WAS READMITTED ON 3/35/97 WITH CELLUTIS ON HIS RIGHT ARM, RIGHT UPPER EPIGASTRIC PAIN AND SWELLING WITH TRACE EDEMA, AND RIGHT UPPER SHOULDER PAIN. ON 3/6/97 PT UNDEWENT PLASMA EXCHANGE WITH FRESH-FROXEN PLASMA AND CELLUITIS HAD RESOLVED BY THAT TIME.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 PROSORBA COLUMN PROTEIN A IMMUNOADSORPTION COLUM LQQ CYPRESS BIOSCIENCE, INC. (FORMERLY IMRE CORP) NA 011897J

Patients

Seq Age Sex Outcome Treatment
1 47 YR Hospitalization